Exhibit 23.1


            CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Board of Directors
Nastech Pharmaceutical Company Inc.:


We consent to incorporation by reference in the registration statements
(No. 333-16507 and No. 333-45264) on Form S-2, (No. 333-44035, No. 333-59472,
No. 333-62800, No. 333-72742, No. 333-108845, No. 333-111324 and No. 333-119429)
on Forms S-3 and (No. 333-28785, No. 333-46214, No. 333-49514, No. 333-92206,
No. 333-92222 and No. 333-118206) on Forms S-8 of Nastech Pharmaceutical Company
Inc. and subsidiary of our reports dated February 18, 2005, with respect to the
consolidated balance sheets of Nastech Pharmaceutical Company Inc. and
subsidiary as of December 31, 2004 and 2003, and the related consolidated
statements of operations, stockholders' equity and comprehensive loss, and cash
flows for each of the years in the three-year period ended December 31, 2004 and
management's assessment of the effectiveness of internal control over financial
reporting as of December 31, 2004 and the effectiveness of internal control over
financial reporting as of December 31, 2004, which reports appear in the
December 31, 2004, annual report on Form 10-K of Nastech Pharmaceutical Company
Inc.


/s/ KPMG LLP
------------

Seattle, Washington
March 1, 2005